Biotrend Cevre ve Enerji Yatirimlari Past Earnings Performance
Past criteria checks 5/6
Biotrend Cevre ve Enerji Yatirimlari has been growing earnings at an average annual rate of 86.3%, while the Renewable Energy industry saw earnings growing at 40.1% annually. Revenues have been growing at an average rate of 62.9% per year. Biotrend Cevre ve Enerji Yatirimlari's return on equity is 31.5%, and it has net margins of 52.4%.
Key information
86.3%
Earnings growth rate
38.0%
EPS growth rate
| Renewable Energy Industry Growth | 55.0% |
| Revenue growth rate | 62.9% |
| Return on equity | 31.5% |
| Net Margin | 52.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Biotrend Cevre ve Enerji Yatirimlari makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,236 | 1,172 | 346 | 0 |
| 31 Dec 23 | 2,233 | 948 | 325 | 0 |
| 30 Sep 23 | 1,683 | 581 | 135 | 0 |
| 30 Jun 23 | 1,442 | 470 | 111 | 0 |
| 31 Mar 23 | 1,336 | 367 | 95 | 0 |
| 31 Dec 22 | 2,338 | 577 | 249 | 0 |
| 30 Sep 22 | 989 | 60 | 81 | 0 |
| 30 Jun 22 | 790 | 10 | 64 | 0 |
| 31 Mar 22 | 597 | 10 | 52 | 0 |
| 31 Dec 21 | 428 | 7 | 42 | 0 |
| 30 Sep 21 | 338 | 62 | 35 | 0 |
| 30 Jun 21 | 301 | 46 | 28 | 0 |
| 31 Mar 21 | 264 | 40 | 25 | 0 |
| 31 Dec 20 | 245 | 50 | 22 | 0 |
| 31 Dec 19 | 92 | 6 | 8 | 0 |
| 31 Dec 18 | 49 | -1 | 7 | 0 |
Quality Earnings: BIOEN has a high level of non-cash earnings.
Growing Profit Margin: BIOEN's current net profit margins (52.4%) are higher than last year (27.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOEN's earnings have grown significantly by 86.3% per year over the past 5 years.
Accelerating Growth: BIOEN's earnings growth over the past year (219.7%) exceeds its 5-year average (86.3% per year).
Earnings vs Industry: BIOEN earnings growth over the past year (219.7%) exceeded the Renewable Energy industry 1.2%.
Return on Equity
High ROE: BIOEN's Return on Equity (31.5%) is considered high.